Manuscripts

Search by keyword, year, or author name.

Showing 1533 manuscripts.

CYP2B6 genetic variants impact the pharmacokinetics of nevirapine and clinical response in HIV-1 infected children receiving HAART.

Akihiko Saitoh, Elizabeth Sarles, Edmund Capparelli, Francesca Aweeka, Andrea Kovacs, Sandra K. Burchett, Andrew A. Wiznia, Sharon Appelbaum Nachman, Terence Fenton, Stephen A. Spector. CYP2B6 genetic variants impact the pharmacokinetics of nevirapine and clinical response in HIV-1 infected children receiving HAART.. AIDS. 2007. 21: 2191 - 2199. PMID: 18090046

Year

2007

Journal

AIDS

Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.

Deborah Persaud, Paul Palumbo, Carrie Ziemniak, Jie (Ellen) Chen, Stuart C. Ray, Michael Hughes, Peter Havens, Murli Purswani, Aditya Gaur, Ellen Gould Chadwick. Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States.. Journal of Infectious Diseases. 2007. 195: 1402-1410. PMID: 17436219

Year

2007

Journal

Journal of Infectious Diseases

Study

P1030

Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021.

Adriana Weinberg, Coleen K. Cunningham, Ross E. McKinney, Elaine J. Abrams, John H. Rodman, M. Robert Blum, ChengCheng Hu, Gregory E. Chittick, Paula Britto, Laurie Reynolds, Michael Hughes, Mobeen H. Rathore, Elizabeth (Betsy) Smith, Leslie Serchuck, Alberto A. Ortiz, Patricia M. Flynn, Ram Yogev, Stephen A. Spector, Linda Draper (Marillo), Melissa Scites, Ruth E. Dickover. Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021.. Pediatrics. 2007. 120: e416-e423. PMID: 17646352

Year

2007

Journal

Pediatrics

Study

P1021

Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women.

Ruth E. Tuomala, Jashvant D. Unadkat, Diane W. Wara, Michael Hughes, Anita A. Mathias, Diane Holland, Mary E. Paul, James D. Connor, Sharon Huang, Bach-Yen Nguyen, Heather D. Watts, Lynne M. Mofenson, Elizabeth (Betsy) Smith, Paul Deutsch, Kathleen A. Kaiser. Pharmacokinetics and safety of indinavir in human immunodeficiency virus-infected pregnant women.. Antimicrobial Agents and Chemotherapy. 2007. 51: 783 - 786. PMID: 17158945

Year

2007

Journal

Antimicrobial Agents and Chemotherapy

Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338).

Susan A. Fiscus, Andrea Kovacs, Leslie A. Petch, ChengCheng Hu, Andrew A. Wiznia, Lynne M. Mofenson, Ram Yogev, Kenneth McIntosh, Stephen Ira Pelton, Sonia Napravnik, Kenneth Stanley, Sharon Appelbaum Nachman. Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338).. AIDS Research & Therapy (online journal). 2007. 4PMID: 17280617

Year

2007

Journal

AIDS Research & Therapy (online journal)

Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO 542) observed in HIV-1-infected children.

Courtney V. Fletcher, Jaime G. Deville, Pearl Samson, John ( Jack ) Moye, Joseph A. Church, Hans ML Spiegel, Paul Palumbo, Terence Fenton, Elizabeth (Betsy) Smith, Bobbie L. Graham, William T. Shearer. Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG2 (PRO 542) observed in HIV-1-infected children.. Journal of Allergy and Clinical Immunology. 2007. 119: 747 - 750. PMID: 17336619

Year

2007

Journal

Journal of Allergy and Clinical Immunology

Long-term observation of adolescents initiating HAART therapy: three-year follow-up.

Patricia M. Flynn, Bret J. Rudy, Jane C. Lindsey, Steven D. Douglas, Janet L. Lathey, Stephen A. Spector, Jaime Martinez, Margarita Silio, Elizabeth (Betsy) Smith, Janice Hodge, Michael Hughes. Long-term observation of adolescents initiating HAART therapy: three-year follow-up.. AIDS Research and Human Retroviruses. 2007. 23: 1208 - 1214. PMID: 17961106

Year

2007

Journal

AIDS Research and Human Retroviruses

Effects of negative life events on measures of quality of life and health utilization among children and youth with HIV infection.

Lois C. Howland, Sybil Crawford, Deborah S. Storm, Katherine Leung, Steven Gortmaker, James M. Oleske. Effects of negative life events on measures of quality of life and health utilization among children and youth with HIV infection.. Journal of the Association of Nurses in AIDS Care. 2007. 18: 3-11. PMID: 17338981

Year

2007

Journal

Journal of the Association of Nurses in AIDS Care

Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS clinical trials group 5084

Jane Hitti, Janet Andersen, Grace McComsey, Tun Liu, Ann J. Melvin, Laura M. Smith, Alice M. Stek, Judith A. Aberg, Andrew D. Hull, Beverly L. Alston-Smith, Heather D. Watts, Elizabeth Livingston. Protease inhibitor-based antiretroviral therapy and glucose tolerance in pregnancy: AIDS clinical trials group 5084. American Journal of Obstetrics and Gynecology. 2007. 196: 331.e1-7.

Year

2007

Journal

American Journal of Obstetrics and Gynecology

A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS clinical trials group study A5115

Sharon A. Riddler, Hongyu Jiang, Allan R. Tenorio, Hairong Huang, Daniel R. Kuritzkes, Edward P. Acosta, Alan Landay, Barbara Bastow, David W. Haas, Karen T. Tashima, Mamta Khandelwal Jain, Steven G. Deeks, John Alexander Bartlett. A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS clinical trials group study A5115. Antiviral Therapy. 2007. 12: 531-41.

Year

2007

Journal

Antiviral Therapy